IMPACT OF ANTENATAL STEROID ADMINISTRATION ON NEONATAL RESPIRATORY OUTCOMES

W HAQ; N NAZ; S TAJ; . ARSH; R BHITTANI

doi:10.54112/bcsrj.v2024i1.692

Authors

W HAQ Lady Reading Hospital Peshawar, Pakistan
N NAZ Lady Reading Hospital Peshawar, Pakistan
S TAJ Lady Reading Hospital Peshawar, Pakistan
. ARSH Lady Reading Hospital Peshawar, Pakistan
R BHITTANI Lady Reading Hospital Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.692

Keywords:

Antenatal steroids, Neonatal respiratory outcomes. Preterm birth, Betamethasone, Dexamethasone, Respiratory Distress Syndrome (RDS) Introduction

Abstract

The administration of antenatal steroids represents a pivotal intervention in obstetric care with profound implications for neonatal respiratory outcomes. The study's main objective is to find the impact of antenatal steroid administration on neonatal respiratory outcomes. This retrospective cohort study was conducted at Lady Reading Hospital Peshawar from July 2019 to June 2023. The study included all infants born at the hospital who met the criteria for preterm birth (gestational age less than 37 weeks). Maternal demographic information was extracted, encompassing maternal age, parity, and medical history. The data collection's primary focus was antenatal steroid administration, including the type of steroid used, dosage, and timing of the gestational age at delivery. Data was collected from 550 preterm infants. The mean maternal age in the antenatal steroid group was 28.5 ± 4.2 years, and 29.1 ± 4.5 years in the no antenatal steroid group. The mean gestational age was 32.2 ± 2.1 weeks and 31.8 ± 2.3, respectively, in both groups. In the antenatal steroid group (n=300), the majority received betamethasone (90.0%) compared to dexamethasone (10.0%). The timing of administration varied, with 16.7% receiving steroids before 28 weeks, 50.0% between 28-32 weeks, and 33.3% between 32-34 weeks. The mean dosage for betamethasone was 10.5 ± 2.3 mg, while dexamethasone had a mean dosage of 8.0 ± 1.5 mg. It is concluded that antenatal steroid administration was associated with a significant reduction in RDS incidence and a lower need for mechanical ventilation among preterm infants. These findings emphasize the clinical importance of timely antenatal steroid administration in improving neonatal respiratory outcomes.

Downloads

Download data is not yet available.

References

Asztalos, E. V., Murphy, K. E., and Matthews, S. G. (2020). A growing dilemma: antenatal corticosteroids and long-term consequences. American Journal of Perinatology 39, 592-600.

Battarbee, A. N., Ros, S. T., Esplin, M. S., Biggio, J., Bukowski, R., Parry, S., Zhang, H., Huang, H., Andrews, W., and Saade, G. (2020). Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes. American journal of obstetrics & gynecology MFM 2, 100077.

DeBolt, C. A., Johnson, S., Harishankar, K., Monro, J., Kaplowitz, E., Bianco, A., and Stone, J. (2022). Antenatal corticosteroids decrease the risk of composite neonatal respiratory morbidity in planned early term cesarean deliveries. American Journal of Perinatology 39, 0915-0920.

Deshmukh, M., and Patole, S. (2021). Antenatal corticosteroids for impending late preterm (34-36+ 6 weeks) deliveries—A systematic review and meta-analysis of RCTs. PLoS One 16, e0248774.

di Pasquo, E., Saccone, G., Angeli, L., Dall'Asta, A., Borghi, E., Fieni, S., Berghella, V., Magnani, C., Frusca, T., and Ghi, T. (2020). Determinants of neonatal hypoglycemia after antenatal administration of corticosteroids (ACS) for lung maturation: data from two referral centers and review of the literature. Early Human Development 143, 104984.

Gulersen, M., Gyamfi-Bannerman, C., Greenman, M., Lenchner, E., Rochelson, B., and Bornstein, E. (2021). Time interval from late preterm antenatal corticosteroid administration to delivery and the impact on neonatal outcomes. American Journal of Obstetrics & Gynecology MFM 3, 100426.

Kearsey, E. O., Been, J. V., Souter, V. L., and Stock, S. J. (2022). The impact of the Antenatal Late Preterm Steroids trial on the administration of antenatal corticosteroids. American Journal of Obstetrics and Gynecology 227, 280. e1-280. e15.

Kongprayoon, P., and Tilagul, T. (2021). The Effect of Antenatal Dexamethasone to Improve Respiratory Neonatal Outcomes in Late Preterm Birth: A Randomized Controlled Trial. Journal of the Medical Association of Thailand 104.

Li, J., Zhang, J., Hao, Q., Du, Y., Lu, J., Chen, H., and Cheng, X. (2022a). Time Interval from Early-Term Antenatal Corticosteroids Administration to Delivery and the Impact on Neonatal Outcomes. Frontiers in Pediatrics 10, 836220.

Li, L., Li, H., Jiang, Y., Yu, B., Wang, X., and Zhang, W. (2022b). The relationship between antenatal corticosteroid administration-to-delivery intervals and neonatal respiratory distress syndrome and respiratory support. Journal of Healthcare Engineering 2022.

Li, X., Zhang, J., Hao, Q., Du, Y., and Cheng, X. (2023). The effect of time interval between antenatal corticosteroid administration and delivery on outcomes in late preterm neonates born to mothers with diabetes: a retrospective cohort study. Frontiers in Pediatrics 11, 1239977.

Morhart, P., Gärtner, J., Weiss, C., Stumpfe, F. M., Dammer, U., Faschingbauer, F., Fahlbusch, F. B., Beckmann, M. W., and Kehl, S. (2022). Influence of timing of antenatal corticosteroid administration on morbidity of preterm neonates. in vivo 36, 1777-1784.

Mpinga, G., Al-Beity, F. M. A., and Manji, K. (2023). Antenatal corticosteroid and early neonatal outcomes among preterm neonates delivered at a tertiary hospital in Tanzania. African Journal of Reproductive Health 27, 23-31.

Mwita, S., Jande, M., Katabalo, D., Kamala, B., and Dewey, D. (2021). Reducing neonatal mortality and respiratory distress syndrome associated with preterm birth: a scoping review on the impact of antenatal corticosteroids in low-and middle-income countries. World Journal of Pediatrics 17, 131-140.

Oladapo, O. T., Vogel, J. P., Piaggio, G., Nguyen, M. H., Althabe, F., Bahl, R., Rao, S. P., De Costa, A., Gupta, S., and Baqui, A. H. (2022). Effect of dexamethasone on newborn survival at different administration-to-birth intervals: A secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial. EClinicalMedicine 53.

Sotiriadis, A., McGoldrick, E., Makrydimas, G., Papatheodorou, S., Ioannidis, J. P., Stewart, F., and Parker, R. (2021). Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes. Cochrane Database of Systematic Reviews.

Taleghani, A. A., Bhriguvanshi, A., Kamath-Rayne, B. D., Liu, C., and Narendran, V. (2020). Timing of antenatal steroid administration and effects on the newborn infant: a retrospective study. American Journal of Perinatology 39, 1065-1073.

Üstün, N., Hocaoğlu, M., Turgut, A., Arslanoğlu, S., and Ovalı, F. (2022). Does antenatal corticosteroid therapy improve neonatal outcomes in late preterm birth? The Journal of Maternal-Fetal & Neonatal Medicine 35, 11-17.